Clinical Trials Browser

Completed × Colorectal Neoplasms × cixutumumab × Clear all

NCT00503685 2018-06-06

Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy

Phase 2 Completed

65 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms